NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for The Multiple Myeloma Research Consortium


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
8th Annual Multiple Myeloma Research Foundation Chicago Awards Dinner Raises $900,000 for Next-Generation Cancer Treatments
2009 JUN 8 ... studies and has initiated 19 clinical trials through its research consortium, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, please visit www.themmrf.org. About ...
Subject: Multiple Myeloma Research Foundation
Price: $3.00
*
Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit
2009 MAY 25 ... year's 7th Annual Dream & Promise Awards Gala, held on Wednesday, May 13, 2009, at the Marriott Marquis in Times Square to support the Children's Brain Tumor Foundation, a ... Club and the Chemical Heritage Foundation, the 2006 Corporate Leadership Award from The Multiple Myeloma Research Foundation, the Star Award of The Leukemia & Lymphoma Society, the 2005 ... principal investigator for the National Cancer Institute-sponsored Pediatric Brain Tumor Consortium where he is a member of the consortium's steering, scientific, new agents and ...
Subject: Brain Cancer
Price: $3.00
*
Cougar Biotechnology Announces Presentation of Positive CB7630 Abiraterone Acetate Phase II Data at ASCO 2009 Genitourinary Cancers Symposium
2009 MAR 16 ... trials of Cougar’s investigational drug CB7630 (abiraterone acetate) were presented at the ASCO Genitourinary Cancers Symposium that is currently taking place in Orlando, Florida. ... with CRPC, who had progressive disease despite treatment with LHRH analogues and multiple other therapies. All of the 53 patients who were enrolled in the trial had radiological ... an inhibitor of microtubule dynamics, which is currently in a Phase I trial in multiple myeloma; and CB1089, an analog of vitamin D, which has been clinically tested in a number of ... being conducted by The Prostate Cancer Clinical Trials Consortium, a national clinical research group sponsored by the Department of Defense, with Dr. Charles J. Ryan, Associate ...
Subject: Cougar Biotechnology, Inc.
Price: $3.00
*
Getting down to cancer basics
2009 APR 13 ... have identified a new cancer gene - one that is common to many cancers and affects the most basic regulation of our genes. The new example - a gene on the X chromosome called ... The new example - a gene on the X chromosome called UTX - is found in 10% of cases of multiple myeloma and 8% of esophageal cancers. UTX plays a role in overall ... epigenetic disregulation may well have a genetic basis." Keywords: DNA Research, DNA Sequence Proteomics, Deoxyribonucleic Acid, Esophageal Cancer, Esophageal ... the type of novel findings we might expect from the International Cancer Genome Consortium." The International Cancer Genome Consortium (ICGC) seeks to catalogue ...
Subject: Wellcome Trust Sanger Institute
Price: $3.00
*
Harvard Business School Awards MMRF Founder, CEO with Alumni Achievement Award
2009 NOV 2 ... clinical studies and has facilitated 20 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, visit www.themmrf.org. ...
Subject: Multiple Myeloma Research Foundation
Price: $3.00
*
In Clinical Trials VELCADE® Bortezomib for Injection as a Foundation of Therapy Continues to Deliver Significant Response Rates in Previously Untreated Multiple Myeloma Patients
2009 JUN 15 ... Millennium: The Takeda Oncology Company reported the presentation of results from two clinical trials of ... of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). An overall response rate (ORR) of 84 percent was observed in one study of ... in newly diagnosed multiple myeloma: Initial results of the Phase I/II Multiple Myeloma Research Consortium Trial Andrzej Jakubowiak, M.D., Ph.D., Associate Professor, University of ...
Subject: Millennium: The Takeda Oncology Company
Price: $3.00
*
MMRC Multiple Myeloma Genomics Initiative First to Sequence Complete Myeloma Genomes
2009 AUG 10 ... clinical studies and has facilitated 19 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, visit www.themmrf.org. About...
Subject: The Multiple Myeloma Research Foundation
Price: $3.00
*
Multiple Myeloma Research Consortium MMRC Activates Clinical Trials 30-40 Percent Faster Than Industry Standard
2009 JUL 6 ... The Multiple Myeloma Research Consortium (MMRC), an innovative research model comprised of a network of 15 academic Member ...
Subject: Multiple Myeloma Research Consortium
Price: $3.00
*
Multiple Myeloma Research Consortium MMRC and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
2009 FEB 2 ... The Multiple Myeloma Research Consortium (MMRC) announced the initiation of the 17th clinical trial in its clinical trial ...
Subject: Multiple Myeloma Research Consortium
Price: $3.00
*
Multiple Myeloma Research Foundation MMRF Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma
2009 MAR 16 ... is now being studied in a clinical trial through the MMRF’s sister organization, the Multiple Myeloma Research Consortium (MMRC). About Multiple Myeloma Multiple myeloma is an incurable cancer of the plasma ...
Subject: The Multiple Myeloma Research Foundation
Price: $3.00
*
Multiple Myeloma Research Foundation MMRF Names Robert Lucas Vice President of Development
2009 NOV 23 ... clinical studies and has facilitated 20 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, visit www.themmrf.org. ...
Subject: The Multiple Myeloma Research Foundation MMRF
Price: $3.00
*
Multiple Myeloma Research Foundation's MMRF Fall Gala Raises More Than $1.8 Million to Advance Cancer Research
2009 NOV 9 ... clinical studies and has facilitated 20 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, visit www.themmrf.org. ...
Subject: Multiple Myeloma Research Foundation MMRF
Price: $3.00
*
National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
2009 MAR 23 ... The National Patient Advocate Foundation (NPAF) - a national, non-profit organization ... provides specialized treatments to patients with blood disorders, leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome. "We are pleased to welcome such ... Affairs at UnitedHealth Group; and Dr. Lovell A. Jones, Director of the Center for Research on Minority Health within the Department of Health Disparities Research and the ... is an affiliate investigator at the Fred Hutchinson Cancer Research Center and a Cancer Consortium member, Stem/Progenitor Cell Biology Program, at the Fred Hutchinson Cancer Research ...
Subject: Biomedicine
Price: $3.00
*
The Multiple Myeloma Research Foundation MMRF and Leukemia & Lymphoma Society LLS Partner to Fund $500,000 in Cancer Stem Cell Research Grants
2009 MAR 2 ... studies and has facilitated 17 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, please visit www.themmrf.org. The Leukemia ...
Subject: The Multiple Myeloma Research Foundation & The Leukemia & Lymphoma Society
Price: $3.00
*
VELCADE® Bortezomib for Injection and Pipeline Data to Be Highlighted at American Society of Clinical Oncology Annual Meeting
2009 JUN 8 ... Millennium: The Takeda Oncology Company announced that more than 49 oral and poster presentations ... examining the use of VELCADE based combinations in patients with previously untreated multiple myeloma (MM), and one poster on the use of a VELCADE based combination in patients with ... meeting shows that VELCADE continues to be an important component of ongoing clinical research in hematologic malignancies,” said Nancy Simonian, M.D., Chief Medical Officer, ... Diagnosed Multiple Myeloma: Initial Results of Phase I/II Multiple Myeloma Research Consortium Trial Lead investigator: Andrzej Jakubowiak, M.D., Ph.D., Associate Professor, ...
Subject: Millennium: The Takeda Oncology Company
Price: $3.00
*
Data from Eight Clinical Trials Facilitated by the Multiple Myeloma Research Consortium MMRC Presented at the American Society of Hematology ASH Annual Meeting
2008 DEC 22 ... The Multiple Myeloma Research Consortium (MMRC) announced that data from eight clinical trials in its portfolio as well as ...
Subject: The Multiple Myeloma Research Foundation
Price: $3.00
*
Multiple Myeloma Research Foundation's MMRF Annual Gala Raises More Than $1.5 Million to Advance Cancer Research
2008 NOV 17 ... studies and has facilitated 15 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, please visit www.themmrf.org. ...
Subject: The Multiple Myeloma Research Foundation
Price: $3.00
*
New cancer findings from P. Tan and co-researchers published
2008 DEC 1 ... "Identifying the complete repertoire of genes and genetic variants that regulate the pathogenesis and ... in BMC Medicine reports the initial results of a multi-institutional consortium for multiple myeloma designed to evaluate the role of germline polymorphisms in influencing multiple ... and progression of human disease is a central goal of post-genomic biomedical research. In cancer, recent studies have shown that genome-wide association studies can be ...
Subject: Cancer
Price: $3.00
*
Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
2008 DEC 22 ... Both Phase 2 clinical trials are being conducted by Proteolix in collaboration with the Multiple Myeloma Research Consortium (MMRC). Activity in Relapsed and Refractory Multiple Myeloma Patients ...
Subject: Myeloma
Price: $3.00
*
The Multiple Myeloma Research Consortium MMRC Announces Initiation of Phase 1B Study of Elotuzumab HuLuc63 Monoclonal Antibody in Combination with REVLIMID and dexamethasone
2008 OCT 27 ... The Multiple Myeloma Research Consortium (MMRC) announced the initiation of a three-drug combination study of elotuzumab (also ...
Subject: The Multiple Myeloma Research Consortium
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login